| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |